U.S. Natural Products Association (NPA) announced that the U.S. Food and Drug Administration (FDA) has formally responded to its petition, confirming that Beta (β) Nicotinamide Mononucleotide (NMN) is lawful for use in dietary supplements.
On September 29, 2025, the U.S. Natural Products Association (NPA) announced that the U.S. Food and Drug Administration (FDA) has formally responded to its petition, confirming that Beta (β) Nicotinamide Mononucleotide (NMN) is lawful for use in dietary supplements.
We provide full-scale global food market entry services (including product registration, ingredient review, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by [email protected]
U.S. FDA Finalizes the Guidance on New Dietary Ingredient Notification Procedures and Timeframes
US FDA Announces Enforcement Discretion Regarding DSHEA Disclaimer Placement on Dietary Supplements
Philippines FDA Reinforces Ban on Therapeutic Claims for Dietary Supplements, Highlights Labeling Compliance
China's overseas food manufacturer registration, commonly referred to as GACC/CIFER registration, has been in force since 2022 and applies to all foreign food manufacturers exporting to China. The system requires eligible producers to obtain registration prior to export, ensuring compliance with China's food safety and regulatory standards.
A new regulatory framework is set to take effect on June 1, 2026, introducing updated requirements and procedures that will further impact overseas manufacturers.
Request a Demo
